Boston Business Journal featured LexaGene in a story about how the company is trying to tackle possible under-reporting of EEE virus.
Boston Business Journal article
LexaGene develops fully automated, rapid molecular testing at the point-of-need for accurate pathogen detection in human clinical diagnostics, veterinary diagnostics, food safety, and other markets.
October 05, 2021 - October 06, 2021
The in-person and virtual event held in New York City attracted more than 550 attendees, including 100 speakers sharing their expertise, insight, and predictions.